Ada Repetto-Llamazares

2PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 29, 2022
Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro.

Marion M Malenge, Astri Fjelde Maaland, Ada Repetto-Llamazares

|Jul 12, 2018
Combination of 177 Lu-lilotomab with rituximab significantly improves the therapeutic outcome in preclinical models of non-Hodgkin's lymphoma.

Ada H V Repetto-Llamazares, Marion M Malenge, Adam O'Shea

Pageof 1

Frequent Collaborators

1 joint publications

Astri Fjelde Maaland

1 joint publications

Anne Hansen Ree